Theradaptive has a total of 48 patents globally, out of which 3 have been granted. Of these 48 patents, more than 85% patents are active. The United States of America is where Theradaptive has filed the maximum number of patents, followed by Europe and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Roswell Biotechnologies.
Theradaptive was founded in 2014. Theradaptive is creating a platform for the administration of therapeutics for a variety of clinical indications, such as orthopedics, soft tissue repair and immuno-oncology.
Do read about some of the most popular patents of Theradaptive which have been covered by us in this article and also you can find Theradaptive patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Theradaptive patent portfolio.
How many patents does Theradaptive have?
Theradaptive has a total of 48 patents globally. These patents belong to 7 unique patent families. Out of 48 patents, 41 patents are active.
How Many Patents did Theradaptive File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Theradaptive applications Filed | Theradaptive Patents Granted |
2023 | 2 | 2 |
2022 | 5 | – |
2021 | 22 | 1 |
2020 | 5 | – |
2019 | 14 | – |
How many Theradaptive patents are Alive/Dead?
Worldwide Patents
How Many Patents did Theradaptive File in Different Countries?
Countries in which Theradaptive Filed Patents
Country | Patent |
United States Of America | 8 |
Europe | 5 |
China | 4 |
Australia | 4 |
Canada | 3 |
Korea (South) | 3 |
Brazil | 3 |
Singapore | 2 |
Taiwan | 2 |
India | 2 |
Hong Kong (S.A.R.) | 2 |
Colombia | 1 |
New Zealand | 1 |
Mexico | 1 |
Where are Research Centers of Theradaptive Patents Located?
The Research Center for Theradaptive is the United States of America.
What Percentage of Theradaptive US Patent Applications Were Granted?
Theradaptive (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Theradaptive patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Theradaptive?
Law Firm | Total Applications | Success Rate |
Wilson Sonsini Goodrich & Rosati | 5 | 100% |
List of Theradaptive Patents
Theradaptive Patents | Title |
US11773138B2 | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
US11192923B2 | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
US20230233740A1 | Osteoinductive Bone Regeneration Material And Production Method Of The Same |
US20230235002A1 | Compositions And Methods For Targeted Therapeutic Delivery To Bone |
US20230203115A1 | Therapeutic Compositions Comprising Graft Materials And Beta Tcp Binding Peptides And Uses Thereof |
US20220395610A1 | Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
US20220323641A1 | Materials For Delivery Of Tetherable Proteins In Bone Implants |
EP4017468A4 | Materials For Delivery Of Tetherable Proteins In Bone Implants |
EP4168059A1 | Osteoinductive Bone Regeneration Material And Production Method Of The Same |
EP4135750A2 | Compositions And Methods For Targeted Therapeutic Delivery To Bone |
EP3902572A4 | A Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
EP3864025A4 | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
CN115916278A | Bone Induction Bone Regeneration Material And Production Method Thereof |
CN115916239A | Compositions And Methods For Targeted Therapeutic Delivery To Bone |
CN113226386A | A Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
CN113166202A | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
WO2022182749A3 | Ceramic Compositions And Methods Of Use |
CA3180156A1 | Compositions And Methods For Targeted Therapeutic Delivery To Bone |
CA3124677A1 | A Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
CA3115298A1 | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
KR1020230011289A | Compositions And Methods For Targeted Therapeutic Delivery To The Bone |
KR1020210107082A | Material For Bone Regeneration Having A Cotton Like Structure Formed Of A Plurality Of Field Spun Fibers |
KR1020210066006A | Polypeptides Comprising Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
AU2021254751A1 | Compositions And Methods For Targeted Therapeutic Delivery To Bone |
AU2021297422A1 | Osteoinductive Bone Regeneration Material And Production Method Of The Same |
AU2019416205A1 | A Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
AU2019357042A1 | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
HK40076451A | Materials For Delivery Of Tetherable Proteins In Bone Implants |
HK40056601A | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
TWI794842B | Osteoinductive Bone Regeneration Material And Production Method Of The Same |
MX2023000200A | Osteoinductive Bone Regeneration Material And Production Method Thereof |
BR112022026092A2 | Osteoinductor Material For Bone Regeneration And Production Method |
CO20230000441A2 | Osteoinductive Bone Regeneration Material And Production Method Thereof |
BR112022020809A2 | Compositions And Methods For Bone Directed Therapeutic Delivery |
SG11202254399QA | Osteoinductive Bone Regeneration Material And Production Method Of The Same |
TW202203961A | Compositions And Methods For Targeted Therapeutic Delivery To Bone |
NZ793255A | Osteoinductive Bone Regeneration Material And Production Method Of The Same |
IN202117026490A | A Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
IN202117021127A | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
SG11202106161PA | A Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
BR112021006752A2 | Polypeptides Including A Tricalcium Beta Phosphate Binding Sequence And Uses Thereof |
US20210023269A1 | Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
WO2021261408A1 | Osteoinductive Bone Regeneration Material And Production Method Of The Same |
WO2021194604A3 | Therapeutic Compositions Comprising Graft Materials And Beta Tcp Binding Peptides And Uses Thereof |
WO2021211683A3 | Compositions And Methods For Targeted Therapeutic Delivery To Bone |
WO2021034958A3 | Materials For Delivery Of Tetherable Proteins In Bone Implants |
WO2020139901A1 | A Bone Regeneration Material Having A Cotton Wool Like Structure Formed Of A Plurality Of Electrospun Fibers |
WO2020077265A1 | Polypeptides Including A Beta Tricalcium Phosphate Binding Sequence And Uses Thereof |
What are Theradaptive key innovation segments?
What Technologies are Covered by Theradaptive?
The chart below distributes patents filed by Theradaptive